ArticlePharmaceuticals (Basel, Switzerland)2025
A Hybrid In Silico Approach for Identifying Dual VEGFR/RAS Inhibitors as Potential Anticancer and Anti-Angiogenic Agents.
Alessia Bono et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.